Infarmed orders market withdrawal of medicine used to treat hepatitis B
Infarmed has ordered the immediate withdrawal of several batches of Entecavir Viatris (formerly Entecavir Mylan) 0.5 mg and 1 mg tablets. The order follows the detection of manufacturing irregularities, including potential contamination and cross-contamination issues.

